BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Other News

STC Biologics, National Cancer Institute (NCI) biosimilars news

Biosimilars company STC received a $2.5 million Small Business Innovation Research contract from NCI to develop biosimilar mAb STC101 to treat cancer. STC also...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >